Drug intelligence / Profile preview

Moshen Digui

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Transdermal
01

Overview

Moshen Digui (MSDG) is a traditional Chinese medicine (TCM) compound formula that has been widely used in China for the treatment of idiopathic membranous nephropathy (IMN), a common cause of nephrotic syndrome in nondiabetic adults. The formula is considered an empirical TCM prescription and is typically administered as part of integrative therapy for IMN. Clinical practice and retrospective data suggest that MSDG can significantly reduce proteinuria and delay disease progression in IMN patients. While its efficacy and safety have been observed clinically, high-quality randomized controlled trials are still lacking. In recent studies, ultrasonic infiltration—a novel drug delivery method—has been explored to improve patient compliance compared to traditional oral administration due to the poor taste of some TCMs[1][2][3].

Brand names
Moshen Digui
Other names
MSDGMoshen Digui prescription
02

Targets

WNT1 (Wnt family member 1)AHR (Aryl hydrocarbon receptor)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)CTNNB1 (Beta-catenin)RELA (Nuclear Factor Kappa B Subunit p65)

Beyond the preview

Go deeper on Moshen Digui.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moshen Digui.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call